An AI model classifies risks of early relapse post-CAR T-cell therapy in a multicenter real-world population with DLBCL.

Wang M, Komanduri KV, Datta D, Patel A, Whitaker B, Belov A, Rubin B, Vashist R, Rodriguez-Monguio R, Cinar P, Anderson S, Butte AJ.

Open source

DOI
10.1182/bloodadvances.2025016375
Published
2025-11-01
Container
Blood Adv
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025016375,
  title = {An AI model classifies risks of early relapse post-CAR T-cell therapy in a multicenter real-world population with DLBCL.},
  author = {Wang M and  Komanduri KV and  Datta D and  Patel A and  Whitaker B and  Belov A and  Rubin B and  Vashist R and  Rodriguez-Monguio R and  Cinar P and  Anderson S and  Butte AJ.},
  year = {2025},
  journal = {Blood Adv},
  doi = {10.1182/bloodadvances.2025016375},
  url = {https://doi.org/10.1182/bloodadvances.2025016375}
}

RIS

TY  - JOUR
TI  - An AI model classifies risks of early relapse post-CAR T-cell therapy in a multicenter real-world population with DLBCL.
AU  - Wang M
AU  -  Komanduri KV
AU  -  Datta D
AU  -  Patel A
AU  -  Whitaker B
AU  -  Belov A
AU  -  Rubin B
AU  -  Vashist R
AU  -  Rodriguez-Monguio R
AU  -  Cinar P
AU  -  Anderson S
AU  -  Butte AJ.
PY  - 2025
JO  - Blood Adv
DO  - 10.1182/bloodadvances.2025016375
UR  - https://doi.org/10.1182/bloodadvances.2025016375
ER  -

APA

M, W., KV, K., D, D., A, P., B, W., A, B., B, R., R, V., R, R., P, C., S, A., & AJ., B. (2025). An AI model classifies risks of early relapse post-CAR T-cell therapy in a multicenter real-world population with DLBCL.. Blood Adv. https://doi.org/10.1182/bloodadvances.2025016375

Source records